La Jolla

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Amyloidosis4 trials
• Metastatic breast cancer2 trials
• Alzheimer disease1 trial
• High blood pressure1 trial
• Liver and biliary tract cancer1 trial

Phase

• Phase 35 trials
• Phase 12 trials

Status

• Recruiting6 trials
• Active, not recruiting1 trial
• Completed1 trial
• Enrolling by invitation1 trial

Lead sponsor

• Alnylam Pharmaceuticals7 trials
• Olema Pharmaceuticals, Inc.2 trials

Running trials

• Recruiting

  DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

  NCT07358078· Alnylam Pharmaceuticals· Source

• Recruiting

  Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

  NCT07085767· Phase 3· Olema Pharmaceuticals, Inc.· Source

  Contact: Olema Pharmaceuticals, Inc.

• Recruiting

  Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  NCT07181109· Phase 3· Alnylam Pharmaceuticals· Source

• Recruiting

  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  NCT07052903· Phase 3· Alnylam Pharmaceuticals· Source

• Recruiting

  A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

  NCT06600321· Phase 1· Alnylam Pharmaceuticals· Source

• Enrolling by invitation

  A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  NCT06679946· Phase 3· Alnylam Pharmaceuticals· Source

• Active, not recruiting

  OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

  NCT06016738· Phase 3· Olema Pharmaceuticals, Inc.· Source

• Recruiting

  ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

  NCT04561518· Alnylam Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Amyloidosis4 recruiting
• High blood pressure1 recruiting
• Liver and biliary tract cancer1 recruiting
• Metastatic breast cancer1 recruiting

Closed trials

• Recruiting

  A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD

  NCT05231785· Phase 1· Alnylam Pharmaceuticals· Source